Lexaria Bioscience Corp. (NASDAQ:LEXX) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on January 13, 2026.
The company reported Q0 revenue of $0.
Lexaria Bioscience Corp.'s stock currently trades at $0.00 with a market capitalization of $0.